TaaS To Partner With Science Blockchain Incubator

La-based incubator’s “company creation engine” to co-invest in promising applications of blockchain technology with groundbreaking, internationally-domiciled, TaaS fund.

Token-as-a-Service (TaaS) announced a strategic partnership with Science Blockchain, an incubator focused on sponsoring and growing leading companies in the blockchain space that recently launched its ICO. The primary goal of the partnership is to reduce the risks and technical barriers of investing in the blockchain space.

Science’s track record and expertise in early stage incubation complements TaaS’ token-sale and post-token-sale crypto-asset fund as well as its technical tools. By working with TaaS, Science and its investors potentially will benefit from greater visibility, investment and liquidity from incubated projects, given TaaS’ platform features that simplify and secure token investment – making it easier, i.e., for investors to enter and participate in ICOs and the crypto space in general. TaaS, for its part will be better able to leverage more early-stage, higher-quality project investments, given Science Blockchain’s legal, technical and operational experience.

“When we met the TaaS team in their hometown of Kyiv at the d10e Conference, we knew a partnership might work beautifully for us both,”* said Science Blockchain Founder Greg Gilman.*“ Both Science and Taas are founding members of the Blockchain Investors Consortium (BIC) and share the view that blockchain technology can and should grow into a mainstream platform for a wide variety of business applications. For that to happen, however, funds like ours, as well as our investor bases, need to lower the barriers to greater sophistication, better tools and more mature approaches to how we identify, support and scale portfolio companies.”

Gilman continued: “TaaS understands this and executes against it as a core part of their business – especially the way their platform simplifies and secures token investment. They’ve also successfully practiced what they preach by using an ICO to support their leadership in making cryptocurrencies easier to leverage and navigate. They are one of the first post-ICO blockchain projects to have produced incredible returns and we are excited to leverage each other’s strengths.”

Ruslan Gavrilyuk, Co-Founder and President of the TaaS, added: “TaaS helped pioneer the idea of a token-as-a-service business, and Science Blockchain’s commitment to scaling innovative applications of blockchain tech is a perfect opportunity for the kind of partnership for which we designed our fund 0 financially sophisticated tech entrepreneurs looking to create mainstream value from an emerging technology. We think the Science Blockchain model is an elegant and sophisticated way to help create numerous quality blockchain businesses, and the SCI token itself is both unique and potentially very valuable as an investment vehicle. We look forward to working with Science and its portfolio companies on improving the business use cases of blockchain technologies, cryptocurrencies and ICOs.”

“When two experienced, professional teams come together from the West and from the East around a shared set of goals, they are bound to create more value that they could individually,“ said Mike Costache, Advisory Board member to both TaaS and Science Blockchain, and Founder of BIC, which currently has 100 crypto-hedge fund members with over $2 billion of digital assets under management. “Having worked closely with TaaS’ founders since before their token-sale (March – April, 2017), we created a high standard for due diligence after looking at over 200 ICOs and invested in 14 so far. I look forward to Science Blockchain making co-investments along side TaaS and the other crypto hedge funds.”

Science Blockchain’s ICO is currently underway, and while the composition of its portfolio is evolving, it’s expected that the completion of the funding event and development of its investments will accelerate the ways in which Science and TaaS will work together both as co-investors and as technology partners.

Notice
The Science ICO tokens are being offered on a limited basis to a maximum of 99 accredited US investors under exemptions from registration with the U.S. Securities and Exchange Commission pursuant to Regulation D, Section 506(c) of the Securities Act of 1933, as amended (the “Securities Act”), and the rule promulgated thereunder. Only accredited investors within the US and non-US persons outside of the US will be eligible to purchase Science ICO tokens. This press release does not constitute an offer to sell or the solicitation of an offer to purchase the Science ICO tokens, nor shall there be any offer, solicitation or sale of the Science ICO tokens in any jurisdiction in which such offer, solicitation or sale would be unlawful. The Science ICO tokens have not and will not be registered under the Securities Act or other applicable state securities laws, and may not be offered or sold in the US absent registration or pursuant to an exemption from registration requirements of the Securities Act and under applicable